Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Amide compound, preparation method and application thereof

A compound and solvate technology, applied in the field of drug invention, can solve the problems of inability to completely withdraw opioid analgesics, weak and unsatisfactory sustained analgesic effect, etc.

Active Publication Date: 2021-03-30
WEST CHINA HOSPITAL SICHUAN UNIV
View PDF6 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In order to meet the above needs, various studies on increasing the nerve block time of local anesthetic drugs have been carried out, but none of them are ideal.
If lidocaine quaternary ammonium salt QX314 is used in combination with surfactants, although the nerve block time can be significantly prolonged, the nerve damage caused by surfactants cannot be ignored (Itay Sagie and Daniel S. Kohane, PNAS, 2010 , 107(8), 3740–3745); another example is that QX314 is derivatized and prepared into cationic long-chain derivatives, although the nerve block time can be prolonged, but this type of molecule itself is a surfactant (CN 105315170B), and it is also unavoidable Nerve and tissue damage caused by surface activity; another example is the combined use of hydroxy derivatives of QX314 and levobupivacaine, although the local nerve block time is prolonged to a certain extent, but it cannot exceed 12 hours (WenLing Zhao et al, European Journal of Pharmaceutical Sciences. 2018, 111, 418–424)
In addition, a bupivacaine sustained-release liposome has been marketed in the United States in recent years. Although the local analgesic effect it can produce can last for 96 hours, it is limited by the safety of bupivacaine. The total amount of bupivacaine is limited, and its sustained analgesic effect is weak, so the use of opioid analgesics cannot be completely withdrawn (Zhang X et al, Medicine (Baltimore). 2017; 96(49):e8433)
[0004] Therefore, at present, there is no local anesthetic with strong effect (can completely avoid the use of opioid receptor agonists), long acting time (24-72 hours strong analgesia) and safety (good local tissue and systemic safety) Local Nerve Blockers, Unmet need for prolonged postoperative local analgesia

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Amide compound, preparation method and application thereof
  • Amide compound, preparation method and application thereof
  • Amide compound, preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0092] Embodiment 1, the preparation of compound 1

[0093]Mix 234mg of lidocaine free base (CAS: 137-58-6) with 5mL of bromoethanol, and stir overnight in a closed reactor at 80°C. The next day, drop the reaction solution into 30mL of diethyl ether, precipitate a solid, and filter to obtain crude product A.

[0094] Mix 232mg of 2-piperidinecarboxylic acid 2,6-dimethylphenylamide (CAS: 15883-20-2) and 181mg of 5-bromo-pentanoic acid in 10mL of acetonitrile, add 400mg of anhydrous potassium carbonate, and stir at 50°C After 6 hours, filter, adjust the pH to 2-3 with 10% methanolic hydrochloric acid solution, evaporate the filtrate to dryness, and obtain crude product B.

[0095] Mix crude product A and crude product B in 10 mL of DMF, drop into 5 mL of DMF solution containing 270 mg of dicyclohexylcarbodiimide (DCC), react at room temperature for 2 hours, evaporate the solvent under reduced pressure, add 20 mL of 1N hydrochloric acid to the residue, stir and Use activated car...

Embodiment 2

[0098] Embodiment 2, the preparation of compound 6

[0099] Dissolve 234 mg of lidocaine free base (CAS: 137-58-6) and 181 mg of methyl 4-bromobutyrate (CAS: 4897-84-1) in 10 mL of acetonitrile, stir at 60°C overnight, and evaporate the solvent to dryness the next day. Add 20 mL of water and 0.2 g of sodium hydroxide, stir at room temperature for 3 hours, adjust the pH value to 2-3 with 1N hydrochloric acid, and evaporate the solvent to dryness under reduced pressure to obtain crude product A.

[0100] 232 mg of 2-piperidinecarboxylic acid 2,6-dimethylphenylamide (CAS: 15883-20-2) was mixed with 139 mg of 3-bromo-propanol (CAS: 627-18-9) in 10 mL of acetonitrile, 70 Stir overnight at ℃, and evaporate acetonitrile to dryness under reduced pressure to obtain crude product B.

[0101] Mix crude product A and crude product B in 10 mL of DMF, drop into 5 mL of DMF solution containing 270 mg of dicyclohexylcarbodiimide (DCC), react at room temperature for 2 hours, evaporate the sol...

Embodiment 3

[0104] Embodiment 3, the preparation of compound 8

[0105] Dissolve 234mg of lidocaine free base (CAS: 137-58-6) and 153mg of methyl bromoacetate (CAS: 96-32-2) in 10mL of acetonitrile, stir overnight at 60°C, evaporate the solvent to dryness the next day, add 20mL of water and 0.2g sodium hydroxide, stirred at room temperature for 3 hours, adjusted the pH value to 2-3 with 1N hydrochloric acid, and evaporated the solvent under reduced pressure to obtain crude product A.

[0106] Mix 232mg of 2-piperidinecarboxylic acid 2,6-dimethylphenylamide (CAS: 15883-20-2) and 125mg of bromoethanol in 10mL of acetonitrile, stir overnight at 50°C, and evaporate the acetonitrile to dryness under reduced pressure to obtain crude product B .

[0107] Mix crude product A and crude product B in 10 mL of DMF, drop into 5 mL of DMF solution containing 270 mg of dicyclohexylcarbodiimide (DCC), react at room temperature for 2 hours, evaporate the solvent under reduced pressure, add 20 mL of 1N hy...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an amide compound, a preparation method and application thereof, and particularly provides a compound as shown in a formula (I), or a salt thereof, or an isotope replacement form thereof, or an optical isomer thereof, or a solvate thereof, or a crystal form thereof, or a prodrug thereof. According to the invention, the local anesthetic effect duration of the compound provided by the invention is obviously longer than that of a contrast drug bupivacaine; and compared with bupivacaine, the compound provided by the invention is higher in titer and better in safety, can bedecomposed and removed from plasma more quickly, and has a very good application prospect in preparation of local anesthetic drugs or local analgesic drugs.

Description

technical field [0001] The invention belongs to the field of pharmaceutical inventions, and relates to a class of amide compounds with local analgesic effect and its preparation and application. Background technique [0002] Local anesthetics can produce a reversible nerve block effect at the drug site, hindering the conduction of pain, thereby exerting a local analgesic effect. All local anesthetics currently used clinically will not produce local anesthesia in animals or humans for more than 6 hours without the aid of slow-release preparations. But in most cases, the duration of local pain is much longer than 6 hours, such as neuropathic pain, pain after joint surgery, cancer pain, pain caused by trauma, etc. For the above-mentioned long-term local pain, due to the lack of local anesthetic drugs with a long enough time-effectiveness, the clinic has to use opioid central analgesics for a long time and in large doses, which makes patients face systemic symptoms such as addi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D211/60C07D265/30C07C237/12A61K31/445A61K31/5375A61K31/5377A61K31/221A61P29/00A61P23/02
CPCC07D211/60C07D265/30C07C237/12A61P29/00A61P23/02Y02P20/55
Inventor 刘进柯博文张文胜杨俊
Owner WEST CHINA HOSPITAL SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products